MedTrace Logo

A Prospective, Open-label, Pivotal Study to Assess Spectacle Hearing Aid Safety and Efficacy

NCT07282028 · Status: RECRUITING · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 89

Last updated 2025-12-15

No results posted yet for this study

Summary

Following informed consent signature and upon verification of eligibility and execution of informed consent, subjects will be assigned a study code. The study comprises two groups. Screening visit will be conducted for both groups and include hearing test battery to assess hearing aid safety and efficacy

Conditions

  • Hearing Loss Mixed

Interventions

DEVICE

Spectacle Hearing Aid

wearing hearing aid for effectiveness assessment by hearing tests and questionnaires

Sponsors & Collaborators

  • Assuta Medical Center

    collaborator OTHER

  • Nuance Hearing

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-07-27
Primary Completion
2026-11-30
Completion
2026-12-31

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07282028 on ClinicalTrials.gov